Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Argos Therapeutics Inc (NASDAQ:ARGS)

5.62
Delayed Data
As of Jun 29
 +0.12 / +2.18%
Today’s Change
1.61
Today|||52-Week Range
13.97
+143.29%
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close5.50
Today’s open5.60
Day’s range5.45 - 5.66
Volume191,808
Average volume (3 months)379,867
Market cap$142.4M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-17.31%
Earnings growth (this year)+54.23%
Earnings growth (next 5 years)--
Revenue growth (last year)-73.74%
P/E ratioNM
Price/Sales91.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+0.36+9.11%
NEOSNeos Therapeutics In...+0.15+1.66%
ECYTEndocyte Inc-0.02-0.61%
INNLInnocoll Holdings PL...+0.15+3.05%
Data as of 06/29/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$518.3K
Annual profit (last year)-$74.8M
Net profit margin-14,428.77%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Vice President-
Finance
Lori R. Harrelson
Corporate headquarters
Durham, North Carolina

Forecasts

Partner Offers

Search for Jobs